Revise BE study Protocol: CDSCO Panel Tells Akum Pharma on Chlorthalidone, Cilnidipine, Bisoprolol FDC
New Delhi: Citing that individual and innovators products should be taken as a reference product in the proposed bioequivalence (BE) study protocol, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akums Drugs and Pharmaceuticals to revise the BE study protocol of the fixed-dose combination […]